|
Market Closed -
NYSE
01:30:00 08/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.710 USD | -0.73% |
|
-1.81% | +50.56% |
| Market Cap | 22Cr 20Cr 18Cr 17Cr 31Cr 2.13TCr 32Cr 220.34Cr 86Cr 1.08TCr 83Cr 81Cr 3.48TCr | P/E 2026 * |
11.4x | P/E 2027 * | 54.6x |
|---|---|---|---|---|---|
| Enterprise Value | 22Cr 20Cr 18Cr 17Cr 31Cr 2.13TCr 32Cr 220.34Cr 86Cr 1.08TCr 83Cr 81Cr 3.48TCr | EV / Sales 2026 * |
2.68x | EV / Sales 2027 * | 3.31x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
|
Boerse Muenchen
| PBDA | Real-time | |
|
Tradegate
| PBDA | Real-time | |
|
Börse Stuttgart
| PBDA | Delayed | |
|
Deutsche Boerse AG
| PBDA | Delayed |
Last Transcript: Protalix BioTherapeutics, Inc.
| 1 day | -0.73% | ||
| 1 week | -1.81% | ||
| Current month | -1.81% | ||
| 1 month | +2.26% | ||
| 3 months | +14.83% | ||
| 6 months | +23.74% | ||
| Current year | +50.56% |
| 1 week | 2.6 |  | 2.77 |
| 1 month | 2.6 | | 2.85 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.6 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 30/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 24/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 01/07/2008 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 01/11/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 30/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | Free | Director | 25,500 | 0.0316% | ||
| 03/09/26 | Free | Chairman | 25,500 | 0.0316% | ||
| 03/09/26 | Free | Chief Executive Officer | 4,80,000 | 0.5957% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.73% | -1.81% | +8.40% | +77.12% | 22Cr | |
| +2.70% | +2.73% | +40.91% | +107.91% | 1,03200Cr | |
| +1.44% | -2.38% | +36.83% | +63.02% | 61TCr | |
| +1.75% | +3.73% | +16.55% | +81.99% | 47TCr | |
| +0.60% | -1.73% | +62.98% | +36.64% | 35TCr | |
| +2.92% | +3.06% | +24.83% | +45.10% | 34TCr | |
| +2.42% | -0.74% | +13.44% | +35.80% | 27TCr | |
| +1.86% | -0.81% | -4.69% | +12.20% | 25TCr | |
| +2.60% | -2.00% | +39.77% | +52.12% | 22TCr | |
| +1.82% | -1.48% | +25.75% | +95.64% | 18TCr | |
| Average | +1.57% | -2.98% | +26.48% | +60.75% | 37.15TCr | |
| Weighted average by Cap. | +1.99% | -3.18% | +31.96% | +69.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.22Cr 7.34Cr 6.85Cr 6.22Cr 12Cr 794.76Cr 12Cr 82Cr 32Cr 404.19Cr 31Cr 30Cr 1.3TCr | 6.65Cr 5.94Cr 5.54Cr 5.03Cr 9.48Cr 643.1Cr 9.55Cr 67Cr 26Cr 327.06Cr 25Cr 24Cr 1.05TCr |
| Net income | 1.96Cr 1.75Cr 1.64Cr 1.49Cr 2.8Cr 189.91Cr 2.82Cr 20Cr 7.68Cr 97Cr 7.37Cr 7.21Cr 310.49Cr | 37.94L 33.9L 31.63L 28.73L 54.1L 37Cr 54.51L 3.8Cr 1.48Cr 19Cr 1.42Cr 1.39Cr 60Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/26/08 | $2.710 | -0.73% | 7,94,483 |
| 06/26/06 | $2.730 | +0.74% | 9,34,737 |
| 05/26/05 | $2.710 | 0.00% | 9,84,060 |
| 02/26/02 | $2.710 | +1.12% | 9,47,405 |
| 01/26/01 | $2.680 | -2.90% | 15,89,280 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
